{"id":54315,"date":"2012-10-16T17:16:05","date_gmt":"2012-10-16T17:16:05","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/health-care-stocks-jj-unitedhealth-get-a-lift-from-earnings-reports.php"},"modified":"2012-10-16T17:16:05","modified_gmt":"2012-10-16T17:16:05","slug":"health-care-stocks-jj-unitedhealth-get-a-lift-from-earnings-reports","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/health-care-stocks-jj-unitedhealth-get-a-lift-from-earnings-reports.php","title":{"rendered":"Health-care Stocks: J&#38;J, UnitedHealth get a lift from earnings reports"},"content":{"rendered":"<p><p>    By Russ Britt,    MarketWatch  <\/p>\n<p>    LOS ANGELES (MarketWatch)  Two health-care giants, Johnson    & Johnson and UnitedHealth Group Inc., moved higher Tuesday    after the companies reported third-quarter earnings that beat    analyst estimates.  <\/p>\n<p>    Shares of Johnson & Johnson \/quotes\/zigman\/230812\/quotes\/nls\/jnj JNJ +1.28%    got the boost that many investors were looking for, climbing    more than a buck at one point as the health-care conglomerate    said adjusted third-quarter earnings were $1.25 a share. That    was ahead of the FactSet consensus of analyst estimates, which    came in at $1.19 a share.  <\/p>\n<p>      Citigroup Chief Executive Vikram Pandit is stepping down,      effective immediately, and will be succeeded by Michael      Corbat.    <\/p>\n<p>    J&J said net income for the quarter was $2.63 billion, or    $1.05 per share including one-time charges, compared with $3.2    billion, or $1.15 a share, for the same period a year ago.    Sales were $17.1 billion against last years $16 billion. The    FactSet consensus called for sales of $17.5 billion, though    analysts said the Street consensus was closer to $17 billion,    meaning the company came in ahead of forecasts.  <\/p>\n<p>    J&J also increased its own forecast for full-year results,    saying that 2012 earnings should come in at $5.05 to $5.10 a    share, up from its earlier prediction of $5.00 to $5.07 a    share.  <\/p>\n<p>    J&J shares should trade higher today in reaction to what    we view as a strong, basically clean quarterly beat, Leerink    Swann analyst Danielle Antalffy said in a note to clients.  <\/p>\n<p>    J&J shares were up 78 cents, or 1.1%, to $69.38 in recent    action.  <\/p>\n<p>    UnitedHealth \/quotes\/zigman\/258846\/quotes\/nls\/unh UNH -1.11% ,    meanwhile, had a similar earnings report but it wasnt as    surprising to investors, and so the share boost wasnt as    great. UnitedHealth previewed its earnings recently. Shares    were up marginally to $57.67 in recent action.  <\/p>\n<p>    The company said net income was $1.56 billion, or $1.50 a    share, compared with $1.27 billion, or $1.17 a share. Revenue    for the health-insurance behemoth was $27.3 billion against    last years $25.3 billion. Analysts said they had expected the    company would earn $1.34 a share.  <\/p>\n<\/p>\n<p>See the original post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.marketwatch.com\/news\/story.asp?guid={3ACC4012-17A6-11E2-A50C-002128049AD6}&amp;siteid=rss&amp;rss=1\" title=\"Health-care Stocks: J&#38;J, UnitedHealth get a lift from earnings reports\">Health-care Stocks: J&#38;J, UnitedHealth get a lift from earnings reports<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) Two health-care giants, Johnson &#038; Johnson and UnitedHealth Group Inc., moved higher Tuesday after the companies reported third-quarter earnings that beat analyst estimates. Shares of Johnson &#038; Johnson \/quotes\/zigman\/230812\/quotes\/nls\/jnj JNJ +1.28% got the boost that many investors were looking for, climbing more than a buck at one point as the health-care conglomerate said adjusted third-quarter earnings were $1.25 a share. That was ahead of the FactSet consensus of analyst estimates, which came in at $1.19 a share.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/health-care-stocks-jj-unitedhealth-get-a-lift-from-earnings-reports.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-54315","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54315"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=54315"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54315\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=54315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=54315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=54315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}